Received May 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTPPVHBHPB | DTAP+IPV+HIB+HEPB (VAXELIS) | MSP VACCINE COMPANY | UNK | — | — |
| HIBV | HIB (PEDVAXHIB) | MERCK & CO. INC. | UNK | — | — |
Inbound call from HCP with questions regarding a patient who was co-administered VAXELIS and PEDVAXHIB; HCP reported that there were no symptomatic events from the patient.; This non-serious spontaneous safety report, with reference number 02791973 (Interaction Number 02791970), was received by partner on 21-APR-2025 and forwarded on 22-APR-2025 from other health professional. Due to the nature of the event, the causality between the events Inbound call from HCP with questions regarding a patient who was co-administered VAXELIS and PEDVAXHIB' and 'HCP reported that there were no symptomatic events from the patient.' and Vaxelis was not applicable. Further information is expected.
Prophylaxis